Witnesses

Marie Bernard, M.D.
Deputy Director, National Institute on Aging, National Institutes of Health

• HHRG-115-FA16-Wstate-BernardM-20171129.pdf
• HHRG-115-FA16-Bio-BernardM-20171129.pdf

Roger Glass, M.D.
Director, Fogarty International Center, National Institutes of Health

• HHRG-115-FA16-Wstate-GlassR-20171129.pdf
• HHRG-115-FA16-Bio-GlassR-20171129.pdf

Mary Mittelman, Dr.P.H.
Research Professor, Alzheimer's Disease and Related Dementias Family Support Program, New York University

• HHRG-115-FA16-Wstate-MittelmanM-20171129.pdf
• HHRG-115-FA16-TTF-MittelmanM-20171129.pdf
• HHRG-115-FA16-Bio-MittelmanM-20171129.pdf

Richard Mohs, Ph.D.
Chief Scientific Officer, Global Alzheimer's Platform Foundation

• HHRG-115-FA16-Wstate-MohsR-20171129.pdf
• HHRG-115-FA16-TTF-MohsR-20171129.pdf
• HHRG-115-FA16-Bio-MohsR-20171129.pdf

Mr. Michael Splaine
Principal, Splaine Consulting

• HHRG-115-FA16-Wstate-SplaineM-20171129.pdf
• HHRG-115-FA16-TTF-SplaineM-20171129.pdf
• HHRG-115-FA16-Bio-SplaineM-20171129.pdf